Marketplace Morning Report: August 8, 2025

Episode: How Trump's Proposed Pharmaceutical Tariffs Could Affect You

Host: David Brancaccio

Introduction

In this episode of Marketplace Morning Report, host David Brancaccio delves into President Donald Trump's latest economic policy proposal: imposing tariffs on imported pharmaceuticals. The discussion explores the potential ramifications of these tariffs on the U.S. healthcare system, patients, and the pharmaceutical industry.

Trump's Pharmaceutical Tariff Proposal

At [01:10], David Brancaccio introduces the primary topic:

"President Trump has been promising tariffs on pharmaceuticals for months. This week he was on TV saying he's planning what he called a small tariff at first on imported prescription drugs, then raising it to maybe 250% over the next year or so." [01:10]

The proposal aims to reduce the U.S. trade deficit and bolster domestic drug manufacturing. However, experts warn of significant consequences for drug pricing and availability.

Impact on Generic Medications

Samantha Fields provides an in-depth analysis of how the tariffs could affect generic drugs, which constitute 90% of prescriptions filled in the U.S. annually:

"90% of prescriptions filled in the US every year are generics. John Murphy at the Association for Accessible Medicines says that includes most pills you'd get at the pharmacy, like blood pressure drugs and statins." [01:39]

John Murphy emphasizes the reliance on imported generics:

"We manufacture about 45% of the pill needs for patients in the United States, and the rest of that is imported from India, Europe, and China." [01:51]

Global Supply Chain Vulnerabilities

The global nature of pharmaceutical supply chains is highlighted, raising concerns about the feasibility of shifting production entirely to the U.S.:

"That's a pretty global supply chain." [01:58]

Marta Voschinska from the Brookings Institution adds:

"The manufacturers that make branded products tend to have facilities on both sides of the pond, and it would be easier for those companies to move more production to the US if necessary than it would be for makers of cheaper generics." [02:15]

Financial Strain on Generic Manufacturers

Mariana Sokal of the Johns Hopkins School of Public Health discusses the financial pressures on generic drug manufacturers:

"For generic drugs, they are not patented, very cheap drugs. The markup for the drug manufacturer is not that high, and manufacturers are already squeezed in their profits for these drugs." [02:36]

This could lead to reduced production and potential drug shortages:

"So with tariffs, Marta Wosinska at Brookings says they could start losing money." [02:49]

Potential Drug Shortages

David Brancaccio voices concerns about the broader implications:

"The cost that I worry about is not that prices for generics might increase, it's that manufacturers just might throw their hands up and say, you know, I don't want to sell in the US Market and that drug shortages could become more common." [02:53]

This scenario poses a significant threat to patient access to essential medications.

Additional Economic Impacts: Gold Tariffs

Transitioning to another economic topic, Brancaccio discusses unexpected tariffs on precious metals:

"Professionals in the gold market fully believe their precious metal would never be tariff since the US itself doesn't produce much gold anymore. But surprise, there will be a tariff on 100 ounce and 1 kilo gold bars." [03:10]

Economist Christopher Lowe from FHN Financial comments:

"I chuckled this morning because of course, you know, most of the gold that's traded is mined outside the U.S. I suppose, you know, in a way it's a foreign produced product just like so many other things." [03:15]

He further explains the challenges of increasing domestic gold production:

"The problem with producing more gold domestically is you have to find it first." [03:20]

Global Affairs: DRC's Sports Sponsorship Amid Crises

The episode also covers international news involving the Democratic Republic of Congo (DRC):

"The DRC has a refugee crisis and at the same time the UN says a peace deal to address a decades-long conflict with Rwanda is in jeopardy. Yet the Congo government is opting to spend big on the sponsorship of soccer." [05:47]

Will Chalk from the BBC adds:

"From next season, the team's training tops will have Dr. Heart of Africa written on them. It's part of a four-year sponsorship deal and the Congolese government says it will raise the profile of the country." [06:33]

Critics argue that the DRC is misallocating funds amidst pressing humanitarian needs:

"The country has 7 million internally displaced people. You have an outbreak of cholera and you have 70 million people living on less than $2.15 a day. And the Congolese government is entering into a marketing promotion agreement, a sponsorship agreement. It just doesn't add up." [07:11]

Federal Reserve Appointment

In financial news, David Brancaccio reports on the Trump administration's appointment of Stephen Myron to the Federal Reserve:

"The President has picked his top economic advisor, Stephen Myron, to a short-term spot at the Federal Reserve." [08:25]

Henry Epp elaborates:

"Myron would fill the seat of Fed Governor Adriana Kugler, who unexpectedly announced her resignation last week. Kugler's term lasts until the end of January, and Trump said that Myron would only fill the seat until then." [08:25]

Myron, a critic of Fed Chair Jerome Powell, could influence upcoming interest rate decisions, pending Senate confirmation.

Conclusion

This episode of Marketplace Morning Report provides a comprehensive overview of President Trump's proposed pharmaceutical tariffs and their potential impact on the U.S. healthcare system. Through expert insights and critical analysis, the report highlights the delicate balance between protecting domestic industries and ensuring affordable access to essential medications for patients. Additionally, the episode touches on related economic and global issues, offering listeners a well-rounded perspective on current events.

Produced by Marketplace's Henry Epp, with contributions from Samantha Fields, Will Chalk, and contributors from the Brookings Institution and Johns Hopkins School of Public Health.